Treatment of Cushing's Disease With R-roscovitine
NCT02160730
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
NIH grant ended.
Conditions
Cushings Disease
Interventions
DRUG:
R-roscovitine
Sponsor
Shlomo Melmed, MD
Collaborators
[object Object]